Can a community program cut the time to treat psychosis?
NCT ID NCT05813457
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a program called PRESTO that aims to identify and treat first-episode psychosis sooner. The program educates the public, trains frontline workers like doctors and teachers, and provides a mobile team to connect patients to care. Researchers will measure whether this reduces the time a person goes untreated, which may improve their long-term outlook. The trial involves 416 participants across multiple centers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PRESTO Early Identification Program (community education, training for frontline workers, and a mobile care team)
What this could lead to
If successful, this program could become a model for reducing delays in treating first-episode psychosis, potentially improving long-term outcomes for patients.
What could go wrong
This is a behavioral intervention study, not a drug trial. Results depend on community uptake and may not be easily replicated in other regions. The study is still recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Montpellier
RECRUITINGMontpellier, 34090, France
Contact
Contact
Contact
-
CHU de Nîmes
RECRUITINGNîmes, 30900, France
Contact
-
Chu Clermont-Ferrand
RECRUITINGClermont-Ferrand, 63003, France
Contact
-
Chu Grenoble
RECRUITINGGrenoble, 38000, France
Contact
-
Chu Saint Etienne
RECRUITINGSaint-Etienne, 42100, France
Contact
Contact
Contact
-
Hospices Civils de Lyon
RECRUITINGBron, 69500, France
Contact